Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
44 hedge funds and large institutions have $76M invested in Alimera Sciences in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 8 closing their positions.
52% more capital invested
Capital invested by funds: $50.1M → $76M (+$25.9M)
4% less funds holding
Funds holding: 46 → 44 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
34% less call options, than puts
Call options by funds: $107K | Put options by funds: $162K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$131K |
| 2 |
Charles Schwab
San Francisco,
California
|
+$126K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$68.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$62K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRC
North Run Capital
Boston,
Massachusetts
|
-$724K |
| 2 |
FNBT
FineMark National Bank & Trust
Fort Myers,
Florida
|
-$122K |
| 3 |
Teacher Retirement System of Texas
Austin,
Texas
|
-$108K |
| 4 |
SIM
Spark Investment Management
New York
|
-$95K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$55.5K |
ALIM Hedge Fund Activity: Q4 2013 in Review
44 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2013, worth a combined $76M — up 52% from $50.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of ALIM and 6 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 10 added.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $131K. The largest seller was North Run Capital, cutting an estimated $724K.
- 44 institutional investors held Alimera Sciences (ALIM) as of Q4 2013, down from 46 in Q3 2013.
- Funds reported $76M of Alimera Sciences stock for Q4 2013, up 52% quarter-over-quarter.
- 6 funds opened new Alimera Sciences positions in Q4 2013 and 8 closed out, a net change of -2 holders.
- The largest Alimera Sciences buyer in Q4 2013 was Goldman Sachs, an estimated $131K added.
- The largest Alimera Sciences seller in Q4 2013 was North Run Capital, an estimated $724K sold.
Based on aggregated 13F filings for Q4 2013.